ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morton, R E
Right arrow Articles by Nicholson, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morton, R E
Right arrow Articles by Nicholson, J
Archives of Disease in Childhood 2004;89:1133-1137
© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health


PERSONAL PRACTICE

Botulinum toxin for cerebral palsy; where are we now?

R E Morton1, J Hankinson2, J Nicholson3

1 Ronnie MacKeith Child Development Centre, Derbyshire Children’s’ Hospital, Derby and Nottingham Queens Medical Centre and City Hospital, Nottingham, UK
2 Physiotherapy Department, Ronnie MacKeith Child Development Centre, Derby, UK
3 Occupational Therapy department, Ronnie MacKeith Child Development Centre, Derby, UK

Correspondence to:
Correspondence to:
Dr R E Morton
Ronnie MacKeith Child Development Centre, Derbyshire Children’s’ Hospital, Derby and Nottingham Queens Medical Centre and City Hospital, Nottingham, UK; richard.morton{at}sdah-tr.trent.nhs.uk


ABSTRACT
In this article, the evidence base for botulinum-A treatment acquired in recent years is outlined, and the practicalities involved in providing this service are described. Botulinum-A is relatively new, and possible improvements for the future are considered.


Abbreviations: BT-A, botulinum A; CP, cerebral palsy; RCT, randomised controlled trial

Keywords: botulinum toxin; cerebral palsy




This article has been cited by other articles:


Home page
PediatricsHome page
K. Bjornson, R. Hays, C. Graubert, R. Price, F. Won, J. F. McLaughlin, and M. Cohen
Botulinum Toxin for Spasticity in Children With Cerebral Palsy: A Comprehensive Evaluation
Pediatrics, July 1, 2007; 120(1): 49 - 58.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health